Dr David Littlejohn

Dr David Littlejohn

Oncoplastic Breast, Endocrine & General Surgeon

MBBS FRACS

Profile:

Dr David Littlejohn has been providing expert General, Breast, Oncoplastic and Endocrine subspecialist surgery services for 24 years. He has been a pioneering leader in the field of oncoplastic surgery in ANZ. He is widely acknowledged and respected in his field. 

Founding chairman of the Oncoplastic group of BreastSurgANZ. Prior Vice President Breast Surgical Society of Australia and New Zealand. 

Having pioneered the development of oncoplastic surgery including cadaveric courses in Australia and NZ, David has been a regular invited speaker at many international and national conferences and is a lecturer for the Sydney University Graduate Certificate in Breast cancer surgery course. 

David has published research into the pioneering use of 4DCT scan for parathyroid surgery in a regional centre and established a thriving Parathyroid and Thyroid surgery practice with audited results that compare very favourably with other units. 

Key Publications

Is Australia lagging behind in the use of neoadjuvant chemotherapy for breast cancer? David R. G. Littlejohn* Department of Surgery, Wagga Wagga Rural Referral Hospital, Calvary Hospital Riverina and the Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia Correspondence to: David R. G. Littlejohn. Suite 5, 325 Edward St. Wagga Wagga, NSW 2650, Australia. Email: offce@littlejohns.com.au. Comment on: Patiniott PD, Wong GY, Lam YH, et al. Neoadjuvant chemotherapy rates for breast cancer in Australia—“are we there yet?”. Ann Breast Surg 2019;3:9. Received: 13 June 2019; Accepted: 24 June 2019; Published: 02 August 2019. doi: 10.21037/abs.2019.07.01 View this article at: http://dx.doi.org/10.21037/abs.2019.07.01 

A rural perspective on minimally invasive parathyroidectomy: optimal preoperative imaging and patient outcomes: Journal: ANZ Journal of Surgery 89(1-2),43-47, 2019 

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.Viviana Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra, Oreste Gentilini, Mauro G Mastropasqua, Giovanni Mazzarol, Samuele Massarut, Jean-Rémi Garbay, Janez Zgajnar, Hanne Galatius, Angelo Recalcati, David Littlejohn, Monika Bamert, Marco Colleoni, Karen N Price, Meredith M Regan, Aron Goldhirsch, Alan S Coates, Richard D Gelber, Umberto Veronesi, Lancet Oncol 2013 Apr 11;14(4):297-305. Epub 2013 Mar 11.Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy. 

Books Published 

1. National Breast and Ovarian Cancer Centre. Follow-up of patients with early breast cancer: a systematic review. National Breast and Ovarian Cancer Centre, Surry Hills, NSW, 2009. Dr Angela Rutherford – Chair, Associate Professor John Boyages, Dr Meagan Brennan, Ms Tina Griffiths, Ms Phillippa Hartney, Dr Warwick Lee, Dr David Littlejohn, Ms Vivienne Luke, Associate Professor Raymond Snyder 

2. Breast cancer management pathways SME UNSW – Riverina November 2018 

Contact Details

Consultation Rooms

Share this post

Thank you for your interest